Hims & Hers will sell weight-loss injectables starting at $200 a month. That's much cheaper than competitors like Ozempic. The online pharmacy's stock shot up 30% Monday on the announcement. Hims & ...
Shares of Hims & Hers tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own compounded version of Novo Nordisk’s Wegovy oral weight-loss drug. After the ...
People are overdosing on the compounded versions of semaglutide drugs like Ozempic and Wegovy, the U.S. Food and Drug Administration said Friday. The two FDA-approved semaglutide injection products ...
The US Food and Drug Administration (FDA) last week warned that differences in how drugmakers and compounders label the strength of injectable drugs may lead to dangerous dosing errors. "Conventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results